Get the Stockscreener App
1.265
5.42%
0.065
Cerus Corp stock is traded at $1.265, with a volume of 1.59M.
It is up +5.42% in the last 24 hours and down -11.54% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$1.20
Open:
$1.19
24h Volume:
1.59M
Relative Volume:
1.34
Market Cap:
$242.50M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-6.0238
EPS:
-0.21
Net Cash Flow:
$-47.77M
1W Performance:
+2.02%
1M Performance:
-11.54%
6M Performance:
-23.33%
1Y Performance:
-41.44%
1-Day Range:
$1.185
$1.29
1-Week Range:
$1.15
$1.29
52-Week Range:
$1.12
$2.39
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.265 | 239.62M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Developing predictive dashboards with Cerus Corporation data2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
Regression analysis insights on Cerus Corporation performanceGlobal Markets & Short-Term High Return Ideas - Newser
Cerus Corporation stock trendline breakdownSell Signal & Real-Time Volume Trigger Notifications - Newser
Is this a good reentry point in Cerus CorporationEarnings Performance Report & Weekly High Return Stock Opportunities - Newser
Analyzing drawdowns of Cerus Corporation with statistical toolsTrade Analysis Report & Weekly Momentum Picks - Newser
Trend analysis for Cerus Corporation this weekEarnings Recap Summary & Consistent Profit Trading Strategies - Newser
Published on: 2025-08-19 14:10:48 - Newser
What high frequency data says about Cerus CorporationMarket Movement Recap & Reliable Breakout Forecasts - Newser
Real time breakdown of Cerus Corporation stock performanceVolume Spike & Real-Time Stock Price Movement Reports - Newser
When is the best time to exit Cerus CorporationMarket Growth Summary & Stock Portfolio Risk Control - Newser
Order flow analysis tools used on Cerus Corporation2025 EndofYear Setup & Safe Swing Trade Setups - Newser
Is it time to cut losses on Cerus Corporation2025 Buyback Activity & Consistent Profit Alerts - Newser
Cerus Corporation recovery potential after sell offPortfolio Growth Summary & Weekly High Return Stock Forecasts - Newser
Reversal indicators forming on Cerus Corporation stock2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
What data driven models say about Cerus Corporation’s futureWeekly Trend Recap & Free Risk Controlled Daily Trade Plans - Newser
Options Data Show Bullish Bias in Cerus Corporation2025 Market Outlook & Real-Time Chart Breakout Alerts - thegnnews.com
What makes Cerus Corporation stock price move sharplyJuly 2025 Spike Watch & Long-Term Safe Return Strategies - Newser
How to monitor Cerus Corporation with trend dashboardsFree Quick Gain Stock Watch With Indicators - Newser
Is Cerus Corporation still worth holding after the dipBuy Strategy Review With Performance Summary - Newser
Cerus stock price target maintained at $4 by Cantor Fitzgerald - Investing.com Nigeria
Can Cerus Corporation Outperform Peers After Recent PullbackGrowth Based Investment Plan Guidance Highlighted - beatles.ru
Cerus Corporation (NASDAQ:CERS) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
Using R and stats models for Cerus Corporation forecastingWeekly Movement Forecast With Chart Signals - Newser
Key External Factors That Drive Cerus Corporation Stock Price MovementsShort-Term Price Breakout Signal Analysis - Newser
Cerus Corporation (NASDAQ:CERS) Q2 2025 Earnings Call Transcript - Insider Monkey
Using portfolio simulators with Cerus Corporation includedReal Chart Based Opportunity Identification - Newser
Cerus: Q2 Earnings Snapshot - Connecticut Post
Earnings call transcript: Cerus Q2 2025 revenue beats forecast, stock dips - Investing.com Canada
Earnings call transcript: Cerus Q2 2025 revenue beats forecast, stock dips By Investing.com - Investing.com South Africa
CERUS CORP SEC 10-Q Report - TradingView
Cerus Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Cerus Corporation Announces Second Quarter 2025 Financial Results - Yahoo Finance
Can trapped investors hope for a rebound in Cerus CorporationEntry Confirmation Based on Volatility Analysis - Newser
Why Cerus Corporation stock attracts strong analyst attentionMarket Sentiment Tracker with Smart Alerts - Newser
How strong is Cerus Corporation company’s balance sheetDiscover stocks with explosive upside potential - Jammu Links News
What are analysts’ price targets for Cerus Corporation in the next 12 monthsMaximize gains with expert trading strategies - Jammu Links News
Should I hold or sell Cerus Corporation stock in 2025Discover market opportunities others miss - Jammu Links News
Is Cerus Corporation stock overvalued or undervaluedGet expert advice on portfolio optimization - Jammu Links News
Published on: 2025-08-03 06:59:46 - Jammu Links News
Intraday pattern recognizer results for Cerus CorporationMonthly Trade Result and Signal Summary - Newser
Cerus Corp expected to post a loss of 3 cents a shareEarnings Preview - TradingView
Published on: 2025-08-01 02:01:44 - Newser
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cerus Corp Stock (CERS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
| Jensen Chrystal | Chief Legal Officer |
Mar 07 '25 |
Sale |
1.50 |
27,457 |
41,131 |
832,318 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):